Suppr超能文献

临床试验中知情同意的神话与现实。

Myth and reality of informed consent in clinical trials.

作者信息

Verheggen F W, van Wijmen F C

机构信息

University Hospital Maastricht, The Netherlands.

出版信息

Med Law. 1997;16(1):53-69.

PMID:9212603
Abstract

Informed consent is a prerequisite for any medical intervention or for participation in scientific research. Legal requirements in health care towards informed consent provide qualifications of information disclosure and focus on procedures to obtain a valid consent. The premise of informed consent as a rational decision making process implies an informed consideration, assessment and patient choice and may be perceived as an ideal in the nature of a myth. These principles and assumptions will be discussed to obtain more insight into informed consent in clinical trials. A cogent model of informed consent is presented, which could be useful in clinical trials. We suggest a gradual distinction between informed consent in regular treatment vs. clinical trials, based on concepts like achievable benefits and risk disclosure. Suggestions are made for further empirical research, to obtain more insight into the myth and reality of informed consent in clinical trials.

摘要

知情同意是任何医疗干预或参与科学研究的先决条件。医疗保健领域对知情同意的法律要求规定了信息披露的条件,并侧重于获得有效同意的程序。作为一个理性决策过程的知情同意的前提意味着经过充分了解后的考虑、评估和患者选择,而这可能被视为一种类似神话性质的理想状态。将对这些原则和假设进行讨论,以更深入地了解临床试验中的知情同意。本文提出了一个有说服力的知情同意模型,该模型可能对临床试验有用。我们建议根据可实现的益处和风险披露等概念,逐步区分常规治疗与临床试验中的知情同意。还提出了进一步实证研究的建议,以更深入地了解临床试验中知情同意的神话与现实。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验